Found: 16
Select item for more details and to access through your institution.
Pharmacokinetics and Pharmacodynamics of Urapidil in Severe Hypertension.
- Published in:
- 1988
- By:
- Publication type:
- Other
Investigation of pegloticase-associated adverse events from a nationwide reporting system database.
- Published in:
- American Journal of Health-System Pharmacy, 2014, v. 71, n. 9, p. 722, doi. 10.2146/ajhp130571
- By:
- Publication type:
- Article
Aging effects on the organic base transporter and stereoselective renal clearance<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 1997, v. 62, n. 2, p. 117, doi. 10.1016/S0009-9236(97)90059-X
- By:
- Publication type:
- Article
Labetalol pharmacokinetics and pharmacodynamics: Evidence of stereoselective disposition.
- Published in:
- Clinical Pharmacology & Therapeutics, 1990, v. 48, n. 5, p. 509, doi. 10.1038/clpt.1990.187
- By:
- Publication type:
- Article
Effects of calcium channel blockers on the pharmacokinetics of propranolol stereoisomers.
- Published in:
- Clinical Pharmacology & Therapeutics, 1990, v. 47, n. 5, p. 584, doi. 10.1038/clpt.1990.79
- By:
- Publication type:
- Article
Effects of age on the protein binding and disposition of propranolol stereoisomers.
- Published in:
- Clinical Pharmacology & Therapeutics, 1990, v. 47, n. 4, p. 447, doi. 10.1038/clpt.1990.56
- By:
- Publication type:
- Article
Pharmacokinetics and pharmacodynamics of dilevalol.
- Published in:
- Clinical Pharmacology & Therapeutics, 1989, v. 46, n. 6, p. 648, doi. 10.1038/clpt.1989.201
- By:
- Publication type:
- Article
The effect of diltiazem on the disposition of encainide and its active metabolites.
- Published in:
- Clinical Pharmacology & Therapeutics, 1989, v. 46, n. 6, p. 668, doi. 10.1038/clpt.1989.203
- By:
- Publication type:
- Article
Comparison of high pressure liquid chromatography and fluorescence polarization immunoassay to assess quinidine pharmacokinetics.
- Published in:
- Biopharmaceutics & Drug Disposition, 1987, v. 8, n. 3, p. 213, doi. 10.1002/bdd.2510080303
- By:
- Publication type:
- Article
Commentary: Should Pharmacogenomic Evidence Be Considered in Clinical Decision Making? Focus on Select Cardiovascular Drugs.
- Published in:
- Pharmacotherapy, 2017, v. 37, n. 9, p. 1005, doi. 10.1002/phar.1979
- By:
- Publication type:
- Article
Alternative Viewpoint: Preparation for Residency.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 8, p. e157, doi. 10.1002/phar.1475
- By:
- Publication type:
- Article
Educational Outcomes Necessary to Enter Pharmacy Residency Training.
- Published in:
- Pharmacotherapy, 2014, v. 34, n. 4, p. e22, doi. 10.1002/phar.1411
- By:
- Publication type:
- Article
Thrombotic Events Associated with C1 Esterase Inhibitor Products in Patients with Hereditary Angioedema: Investigation from the United States Food and Drug Administration Adverse Event Reporting System Database.
- Published in:
- Pharmacotherapy, 2012, v. 32, n. 10, p. 902, doi. 10.1002/j.1875-9114.2012.01126
- By:
- Publication type:
- Article
Antiplatelet Therapy in Patients with Unstable Angina and Non-ST-Segment-Elevation Myocardial Infarction: Findings from the CRUSADE National Quality Improvement Initiative.
- Published in:
- Pharmacotherapy, 2007, v. 27, n. 8, p. 1145, doi. 10.1592/phco.27.8.1145
- By:
- Publication type:
- Article
A Response to: Letter to the Editor Regarding "Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: a Narrative Review".
- Published in:
- 2020
- By:
- Publication type:
- Letter
Critical Differences Between Dietary Supplement and Prescription Omega-3 Fatty Acids: A Narrative Review.
- Published in:
- 2020
- By:
- Publication type:
- journal article